UBE2D1
Ubiquitin-conjugating enzyme E2 D1
Also known as: E2(17)KB1, SFT, UB2D1_HUMAN, UBC4/5, UBCH5, UbcH5A
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P51668
- Gene
- UBE2D1
- Ensembl
- ENSG00000072401
- Chromosome
- 10
- Canonical length
- 147 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Cytosol
OverviewNCBI Gene
The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. This enzyme is closely related to a stimulator of iron transport (SFT), and is up-regulated in hereditary hemochromatosis. It also functions in the ubiquitination of the tumor-suppressor protein p53 and the hypoxia-inducible transcription factor HIF1alpha by interacting with the E1 ubiquitin-activating enzyme and the E3 ubiquitin-protein ligases. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2011]
Canonical amino-acid sequenceUniProt
147 residues, UniProt reviewed canonical sequence.
>P51668|UBE2D1
1 MALKRIQKEL SDLQRDPPAH CSAGPVGDDL FHWQATIMGP PDSAYQGGVF FLTVHFPTDY
61 PFKPPKIAFT TKIYHPNINS NGSICLDILR SQWSPALTVS KVLLSICSLL CDPNPDDPLV
121 PDIAQIYKSD KEKYNRHARE WTQKYAMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against UBE2D1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 130 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 130 nTPM
- tongue: 61 nTPM
- heart muscle: 31 nTPM
- bone marrow: 31 nTPM
- appendix: 16 nTPM
- urinary bladder: 14 nTPM
Single-cell type
- neutrophils: 1,082 nCPM
- esophageal apical cells: 311 nCPM
- myonuclei: 310 nCPM
- monocytes: 275 nCPM
- neutrophil progenitors: 250 nCPM
- syncytiotrophoblasts: 211 nCPM
Immune cell
- neutrophil: 113 nTPM
- classical monocyte: 39 nTPM
- intermediate monocyte: 27 nTPM
- non-classical monocyte: 24 nTPM
- total PBMC: 23 nTPM
- myeloid DC: 20 nTPM
Brain region
- pons: 11 nTPM
- cerebellum: 10 nTPM
- medulla oblongata: 10 nTPM
- white matter: 10 nTPM
- midbrain: 10 nTPM
- spinal cord: 9.9 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.82
- gnomAD pLI
- 0.12
- gnomAD missense Z
- 2.03
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of BMP signaling pathway
- negative regulation of TORC1 signaling
- negative regulation of transcription by RNA polymerase II
- positive regulation of protein polyubiquitination
- positive regulation of protein ubiquitination
- proteasome-mediated ubiquitin-dependent protein catabolic process
- protein K48-linked ubiquitination
- protein polyubiquitination
- ubiquitin-dependent protein catabolic process
Molecular functions
- ATP binding
- ubiquitin conjugating enzyme activity
- ubiquitin protein ligase activity
- ubiquitin-protein transferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of UBE2D1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads UBE2D1 as an antibody target. Whether an autoantibody or antibody against UBE2D1 could matter depends on whether native UBE2D1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
UBE2D1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label UBE2D1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...